Long‐term survival among 5‐year survivors of adolescent and young adult cancer
Amy M. Berkman(St. Jude Children's Research Hospital), Michael Roth(The University of Texas MD Anderson Cancer Center), Kelly W. Merriman(The University of Texas MD Anderson Cancer Center), Carlos H. Bárcenas(The University of Texas MD Anderson Cancer Center), Nancy You(The University of Texas MD Anderson Cancer Center), Jian Wang(Fujian Normal University), John de Groot(University of California, San Francisco), Diane C. Bodurka(The University of Texas MD Anderson Cancer Center), Anita K. Ying(The University of Texas MD Anderson Cancer Center), April DePombo(The University of Texas MD Anderson Cancer Center), Seyedeh Dibaj(The University of Texas MD Anderson Cancer Center), Jennifer L. McQuade(The University of Texas MD Anderson Cancer Center), Michelle A.T. Hildebrandt(The University of Texas MD Anderson Cancer Center), J. Andrew Livingston(The University of Texas MD Anderson Cancer Center), Hun Ju Lee(The University of Texas MD Anderson Cancer Center)
Cited by 56
Related Papers
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
|Science|2021|876
Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
|Annals of Oncology|2016|822
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis
|The Lancet Oncology|2018|658
Effect of Surgeon Specialty on Processes of Care and Outcomes for Ovarian Cancer Patients
|JNCI Journal of the National Cancer Institute|2006|415
Double hit lymphoma: the <scp>MD A</scp> nderson <scp>C</scp> ancer <scp>C</scp> enter clinical experience
|British Journal of Haematology|2014|364